The quality of medical cannabis care varies more than almost any other part of the patient experience. At one end are clinicians who take a full history, consider interactions and follow up. At the other are services that issue a recommendation after a three-minute video call.
Both produce the same piece of paper. Only one produces useful care.
Not medical advice. TruMo Analytics is a cannabis testing laboratory, not a healthcare provider and not a referral service. This describes what good clinical care looks like so you can recognise it.
Oklahoma’s 2026 Requirement
Since 1 January 2026, physicians who recommend medical cannabis in Oklahoma must be registered with OMMA and must have completed approved medical cannabis education before issuing a recommendation.
For patients, this has a practical consequence: confirm your physician is OMMA-registered before the appointment. A recommendation from an unregistered physician will not support an application. This matters most with telehealth services, where the physician may not be who you assume.
What a Good Consultation Involves
A proper appointment covers the same ground as any other clinical consultation.
A full history. What you are dealing with, how long, what you have tried, what worked and what did not.
A complete medication review. Everything — prescriptions, over-the-counter medicines, supplements, herbal products. Cannabinoids affect the enzymes that metabolise many drugs, and this is the single most clinically important part of the appointment. See cannabis and drug interactions.
Relevant risk assessment. Cardiovascular history, because THC raises heart rate. Psychiatric history, including family history, because of the association between high-potency cannabis and psychosis risk. Substance use history. Pregnancy or breastfeeding.
A discussion of what to expect. Which formats might suit, roughly what dosing looks like, what side effects are common, and what would warrant stopping.
A follow-up plan. Cannabis is not a single-decision treatment. A clinician who does not want to hear how it went is not managing your care.
Warning Signs
Several things distinguish a certification service from clinical care.
- No medication review. The most serious omission. Interactions are the main clinical risk and this is where they would be caught.
- Approval guaranteed in advance. A clinician who has decided before assessing you is not assessing you.
- No discussion of risks. A balanced conversation includes what could go wrong.
- An appointment measured in minutes. A genuine history takes longer than that.
- No follow-up offered.
- Product recommendations tied to a specific dispensary. That is a commercial relationship, not clinical advice.
Preparing for the Appointment
You will get more out of it with a little preparation.
Bring a complete written list of every medication and supplement with doses. Bring a summary of your condition and its history — when it started, how it has progressed, what has been tried. Bring relevant records if you have them.
Write down your questions in advance. And be straightforward about any current or previous cannabis use. It is clinical information, not a confession, and withholding it leads to worse advice.
Cannabis Alongside Conventional Care
The framing that causes problems is cannabis as an alternative to conventional medicine. The framing that works is cannabis as one option within it.
In practice that means your other clinicians know about it. A cardiologist, an oncologist, a psychiatrist, a pharmacist and a GP all have reason to know, because it can affect what they prescribe and how they interpret what they see.
It also means not stopping existing treatment without discussing it. This is a real pattern and a genuinely dangerous one — patients discontinuing anticonvulsants, psychiatric medication or cardiac drugs on the basis that cannabis is working. Withdrawal effects from some medications are serious in their own right, separate from the loss of therapeutic benefit.
Pharmacists are underused here. They are the most accessible medication-interaction expertise available, and most people never ask.
Why Integration Is Harder Than It Should Be
Several structural problems get in the way.
Many physicians received no training on the endocannabinoid system or on cannabis, because it was not in the curriculum. Federal scheduling has limited both research and prescribing familiarity. Some clinicians are reluctant for professional or institutional reasons. And “recommendation” is not “prescription” — the legal framework itself keeps cannabis at arm’s length from ordinary practice.
The result is that patients often end up as the point of coordination between clinicians who are not talking to each other. That is not ideal, and being organised about it — keeping your own records, telling everyone, bringing your log — is the practical response. See dosage basics.
What Your Clinician Cannot Tell You
One gap worth naming: most clinicians cannot advise on product quality.
Whether a specific product was properly tested, what the certificate of analysis shows, whether contaminant panels were run — that is not clinical knowledge and it is not what they are trained on.
That part is on you, and it is not difficult. Check that a product has a current COA, that the batch matches, and that contaminants were tested rather than potency alone. See how to choose tested cannabis products and reading lab results.
The Point
A recommendation is a legal document. Clinical care is a relationship with someone who knows your history, reviews your medications, sets expectations and follows up.
The first is easy to obtain. The second is what actually helps, and it is worth looking for specifically.